Labiotech.eu

News and Trends 25 Oct 2019

EU Court Ushers in the Use of Phages Against Listeria in Food

Amidst recent listeria outbreaks in Europe, the European Court of Justice has issued a court order in favor of the company Micreos Food Safety allowing the use of its phage technology to keep listeria at bay in food. Bacteriophages, or phages for short, are viruses that only kill specific bacterial strains and are harmless to […]

October 25, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

biorelate artificial intelligence cell gene therapy

Startup Scout 25 Oct 2019

This UK AI Tool Researches Diseases for Drug Discovery Companies

The Manchester-based company Biorelate is developing artificial intelligence (AI) technology that can collect biological data from the internet and speed up the drug discovery process. Mission: Develop AI technology that trawls the web for disease and drug data and collects it together like researchers would do manually in drug discovery. Biorelate’s product is able to […]

October 25, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 24 Oct 2019

British AI Firm Gets €9M Boost to Develop Drug-Discovery Tech

London-based LabGenius has secured €8.9M in Series A funding, which the company plans to use to scale up its AI- and robotics-based drug development technology. LabGenius focuses on developing protein-based therapeutics using its ‘robot scientist’ EVA. “By transforming how these drugs are discovered, we have a shot at improving the lives of countless people,” said […]

October 24, 2019 - 2 minutesmins - By Helen Albert

alzheimers disease treatment vivoryon therapeutics

News and Trends 24 Oct 2019

German Alzheimer’s Drug Backed with €43M After Biogen’s Surprise Turnaround

The German company Vivoryon Therapeutics has raised €43M on Euronext Amsterdam to fund a phase IIb trial of a drug that could slow the progression of Alzheimer’s disease by blocking toxic forms of the protein amyloid-beta. Vivoryon Therapeutics, previously known as Probiodrug, raised the money using a rights offering and a private placement on Euronext […]

October 24, 2019 - 2 minutesmins - By Jonathan Smith

Interview 23 Oct 2019

Channeling the Power of AI into Personalizing Medicine

Artificial intelligence has been much discussed of late, but will it really help us solve important problems like how to bring personalized medicine to as many patients as possible? Kate Hilyard, COO of Healx in Cambridge in the UK, believes it can. Getting a drug to clinical trials currently requires a large investment of both […]

October 23, 2019 - 7 minutesmins - By Helen Albert

News and Trends 22 Oct 2019

Austrian Biotech Will Develop Viral Protein For Vaginal Infection

The Austrian biotech company PhagoMed Biopharma is developing a viral protein that could one day treat the common condition bacterial vaginosis without disrupting the microbiome as traditional antibiotics do. The preclinical drug candidate is derived from a protein called an endolysin. Endolysins are made by bacteria-hunting viruses called bacteriophages and kill bacteria by rupturing the […]

October 22, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 21 Oct 2019

Update: Abivax’s Ulcerative Colitis Drug Effective Long-Term

Update (21/10/2019): An extension of French biotech Abivax’s phase IIa trial shows its treatment for the inflammatory bowel disease ulcerative colitis has good efficacy after a year of treatment, with 75% of the screened patients remaining symptom-free. Of the 32 patients in the original phase IIa trial, 19 patients were treated with Abivax’s drug in […]

October 21, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

paris ermium therapeutics autoimmune disease

Startup Scout 18 Oct 2019

This Biotech Fights Autoimmune Disease with Rare Immune Cells

We come to the biotech hub of Paris, France, where the biotech Ermium Therapeutics is developing treatments for autoimmune diseases that don’t suppress the whole immune system as current treatments do. Mission: To develop small molecule drugs for autoimmune conditions such as lupus by selectively blocking the activity of a rare type of immune cells […]

October 18, 2019 - 3 minutesmins - By Jonathan Smith

More News! 17 Oct 2019

Sofinnova Partners Raises €333M for its Newest Life Sciences-Focused Fund

Sofinnova Partners, Europe’s largest VC focused on life sciences, has raised €333M to fund early-stage healthcare companies, bringing the total capital managed by the firm to €2B. Sofinnova Partners aims to invest around two-thirds of the new fund, called Sofinnova Capital IX, in European life science companies. The other third will be invested globally, with […]

October 17, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 17 Oct 2019

Innate Pharma Raises €62M IPO to Develop Antibody Drugs for Cancer

The French company Innate Pharma has raised a Nasdaq IPO of €62.1M ($68.8M) to fund the development of antibody immunotherapies for solid tumors and blood cancer. Innate Pharma’s lead candidate antibody monalizumab is being co-developed in phase II with AstraZeneca for the treatment of head and neck cancer and colorectal cancer. Monalizumab is a member […]

October 17, 2019 - 2 minutesmins - By Jonathan Smith

cancer immunotherapy gammadelta therapeutics adaptate biotherapeutics

News and Trends 16 Oct 2019

GammaDelta Therapeutics Spins Out Cancer Immunotherapy Biotech

The UK biotech GammaDelta Therapeutics has founded Adaptate Biotherapeutics to develop cancer immunotherapies based on antibodies that boost a rare type of immune cell. Adaptate Biotherapeutics is a spin-out of GammaDelta Therapeutics, a London company founded in 2016 that specializes in using a rare type of immune cells, known as gamma delta T-cells, to fight […]

October 16, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 16 Oct 2019

UK Firm Raises €51M to Repurpose Drugs for Rare Diseases Using AI

The Cambridge-based artificial intelligence company Healx has raised a Series B round of €50.8M to launch an AI tool that reduces the time it takes to develop treatments for rare diseases by five years. The Series B round was led by the UK VC firm Atomico and includes the returning investor Jonathan Milner, the founder […]

October 16, 2019 - 2 minutesmins - By Jonathan Smith

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

EU Court Ushers in the Use of Phages Against Listeria in Food

This UK AI Tool Researches Diseases for Drug Discovery Companies

British AI Firm Gets €9M Boost to Develop Drug-Discovery Tech

German Alzheimer’s Drug Backed with €43M After Biogen’s Surprise Turnaround

Channeling the Power of AI into Personalizing Medicine

Austrian Biotech Will Develop Viral Protein For Vaginal Infection

Update: Abivax’s Ulcerative Colitis Drug Effective Long-Term

This Biotech Fights Autoimmune Disease with Rare Immune Cells

Sofinnova Partners Raises €333M for its Newest Life Sciences-Focused Fund

Innate Pharma Raises €62M IPO to Develop Antibody Drugs for Cancer

GammaDelta Therapeutics Spins Out Cancer Immunotherapy Biotech

UK Firm Raises €51M to Repurpose Drugs for Rare Diseases Using AI

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!